Single dose of Pfizer BioNTech vaccine can reduce asymptomatic SARS-CoV-2 infections
Single dose of Pfizer BioNTech vaccine can reduce asymptomatic SARS-CoV-2 infections New data from Addenbrooke's Hospital in Cambridge suggests that a single dose of the Pfizer BioNTech vaccine can reduce by four-fold the number of asymptomatic SARS-CoV-2 infections. This implies that the vaccine could significantly reduce the risk of transmission of the virus from people who are asymptomatic, as well as protecting others from getting ill. The study by a team at Cambridge University Hospitals NHS Foundation Trust (CUH) and the University of Cambridge analyzed results from thousands of COVID-1...